JPRN-UMIN000003947招募中未知
Evaluation of eicosapentaenoic acid (EPA) for preventing the progression of coronary atherosclerosis and revascularization in patients with dyslipidemia who underwent percutaneous coronary intervention (PCI) - Evaluation of EPA for preventing the progression of coronary sclerosis and revascularization in post-PCI patients with dyslipidemia
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients who have hypersensitivity to EPA 2) Patients who had cerebral accident in the past 6 months 3) Pregnant women and women suspected of being pregnant 4) Patients with gastrointestinal ulcer in active phase 5) Patients with bleeding 6) Patients who have very poor choleresis or severe liver dysfunction 7) Patients who are ineligible for this study 8) Patients with severe renal dysfunction or undergoing dialysis
研究者
相似试验
尚未招募
3 期
Analysis for effect of Eicosapentaenoic acid (EPA) on aberrant crypt foci (ACF)Subjects with aberrant crypt foci (ACF)JPRN-UMIN000001551Gastroenterology Division, Yokohama City University Graduate School of Medicine100
尚未招募
4 期
Fish Oil in Work Stress StudyACTRN12610000404022HMRC110
招募中
不适用
Preventive effects of Eicosapentaenoic acid (EPA) on stroke recurrence and a symptom state in chronic stroke patients with dyslipidemia.JPRN-UMIN000006416Tokyo Women's Medical University100
尚未招募
不适用
Prognostic effects of eicosapentaenoic acid (EPA) in patients with atherosclerotic diseasesPatients with atherosclerotic diseasesJPRN-UMIN000012852ational hospital organization Minamiwakayama Medical Center100
尚未招募
4 期
Study of the Efficacy and Safety of EPA in Patients With Type-2 DiabetesDiabetes Type 2Diabetes MellitusHypertriglyceridemiaNCT06129526University of Ioannina450